Our study results revealed higher levels of mean plasma complement C4, C3, and ACLA-IgG in aPL-positive subjects with a history of thrombosis, but lower levels of complement C4, C3, and ACLA-IgG among aPL-positive subjects with SLE. This evidence concerns the gene C4A and deep vein thrombosis.